ipsas 29—financial instruments: recognition and measurement - IFAC
ipsas 29—financial instruments: recognition and measurement - IFAC
ipsas 29—financial instruments: recognition and measurement - IFAC
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
FINANCIAL INSTRUMENTS: RECOGNITION AND MEASUREMENT<br />
the group is above its amortized cost, does IPSAS 29 allow non-<strong>recognition</strong> of<br />
the impairment of the first asset?<br />
No. If an entity knows that an individual financial asset carried at amortized cost is<br />
impaired, IPSAS 29.72 requires that the impairment of that asset should be<br />
recognized. It states: “the amount of the loss is measured as the difference between<br />
the asset’s carrying amount <strong>and</strong> the present value of estimated future cash flows<br />
(excluding future credit losses that have not been incurred) discounted at the<br />
financial asset’s original effective interest rate” (emphasis added). Measurement of<br />
impairment on a portfolio basis under IPSAS 29.73 may be applied to groups of<br />
small balance items <strong>and</strong> to financial assets that are individually assessed <strong>and</strong> found<br />
not to be impaired when there is indication of impairment in a group of similar assets<br />
<strong>and</strong> impairment cannot be identified with an individual asset in that group.<br />
E.4.8 Impairment: Recognition of Collateral<br />
If an impaired financial asset is secured by collateral that does not meet the<br />
<strong>recognition</strong> criteria for assets in other St<strong>and</strong>ards, is the collateral recognized as<br />
an asset separate from the impaired financial asset?<br />
No. The <strong>measurement</strong> of the impaired financial asset reflects the fair value of the<br />
collateral. The collateral is not recognized as an asset separate from the impaired financial<br />
asset unless it meets the <strong>recognition</strong> criteria for an asset in another St<strong>and</strong>ard.<br />
E.4.9 Impairment of Non-Monetary Available-For-Sale Financial<br />
Asset<br />
If a non-monetary financial asset, such as an equity instrument, measured at<br />
fair value with gains <strong>and</strong> losses recognized in net assets/equity becomes<br />
impaired, should the cumulative net loss recognized in net assets/equity,<br />
including any portion attributable to foreign currency changes, be reclassified<br />
from net assets/equity to surplus or deficit as a reclassification adjustment?<br />
Yes. IPSAS 29.76 states that when a decline in the fair value of an available-for-sale<br />
financial asset has been recognized in net assets/equity <strong>and</strong> there is objective<br />
evidence that the asset is impaired, the cumulative net loss that had been recognized<br />
in net assets/equity should be recognized in surplus or deficit even though the asset<br />
has not been derecognized. Any portion of the cumulative net loss that is attributable<br />
to foreign currency changes on that asset that had been recognized in net<br />
assets/equity is also recognized in surplus or deficit. Any subsequent losses,<br />
including any portion attributable to foreign currency changes, are also recognized in<br />
surplus or deficit until the asset is derecognized.<br />
E.4.10 Impairment: Whether the Available-For-Sale Reserve in Net<br />
Assets/Equity can be Negative<br />
IPSAS 29 requires that gains <strong>and</strong> losses arising from changes in fair value on<br />
available-for-sale financial assets are recognized in net assets/equity. If the<br />
IPSAS 29 IMPLEMENTATION GUIDANCE 1194